お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙:ジェネリック医薬品の世界市場:種類別・用途別・薬剤送達の経路別・形状別・調達先別・流通チャネル別・企業別・地域別の将来予測と市場機会 (2026年)
市場調査レポート
商品コード
998647

ジェネリック医薬品の世界市場:種類別・用途別・薬剤送達の経路別・形状別・調達先別・流通チャネル別・企業別・地域別の将来予測と市場機会 (2026年)

Global Generic Drugs Market, By Type, By Application, By Drug Delivery, By Form, By Source, By Distribution Channel, By Company, By Region, Forecast & Opportunities, 2026

出版日: | 発行: TechSci Research | ページ情報: 英文 118 Pages | 納期: お問合せ

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=111.74円

こちらのレポートには、数時間(ご購入金額の10%)分のアナリストへの質問/追加調査サービスが含まれております。

ジェネリック医薬品の世界市場:種類別・用途別・薬剤送達の経路別・形状別・調達先別・流通チャネル別・企業別・地域別の将来予測と市場機会 (2026年)
出版日: 2021年04月01日
発行: TechSci Research
ページ情報: 英文 118 Pages
納期: お問合せ
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のジェネリック医薬品の市場規模は、2020年に3710億4000万米ドル、2026年までに5644億3000万米ドルに達すると予測されています。

また、予測期間中に7.08%のCAGRで成長する見通しです。市場の主な促進要因として、慢性疾患の有病率の上昇などが挙げられます。地域別に見ると、アジア太平洋諸国での今後の大幅な市場成長が見込まれています。

当レポートでは、世界のジェネリック医薬品の市場について分析し、全体的な市場規模の動向見通しや市場シェア構造 (種類別・用途別・薬剤送達の経路別・形状別・調達先別・流通チャネル別) 、地域別・主要国の詳細動向 (2016年~2020年/2021年~2026年)、主な市場促進・抑制要因、企業間の市場競争構造、主要企業のプロファイル、今後の市場成長の方向性などを調査しております。

目次

第1章 製品概要

第2章 分析方法

第3章 世界のジェネリック医薬品市場に対するCOVID-19の影響

第4章 エグゼクティブサマリー

第5章 顧客側の見解

  • ブランド認知度
  • 世界のジェネリック医薬品市場の促進要因
  • 医薬品購入の決定に影響を与える要因

第6章 世界のジェネリック医薬品市場:将来展望

  • 市場規模とその予測
    • 金額ベース
  • 市場シェアとその予測
    • 種類別 (小分子ジェネリック、バイオシミラー)
    • 用途別 (心血管疾患、糖尿病、神経疾患、腫瘍、抗炎症性疾患、その他)
    • 薬剤送達の経路別 (経口、局所、非経口、その他)
    • 形状別 (錠剤、カプセル、注射、その他)
    • 調達先別 (自社製造/CMO (委託製造機関))
    • 流通チャネル別 (病院薬局、小売薬局、オンライン薬局、その他)
    • 地域別
    • 企業別 (2020年)
  • 製品市場マップ

第7章 北米のジェネリック医薬品市場:将来展望

  • 市場規模とその予測
  • 市場シェアとその予測
  • 北米市場:国別分析
    • 米国のジェネリック医薬品市場の見通し
    • カナダのジェネリック医薬品市場の見通し
    • メキシコのジェネリック医薬品市場の見通し

第8章 欧州のジェネリック医薬品市場:将来展望

  • 市場規模とその予測
  • 市場シェアとその予測
  • 欧州市場:国別分析
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン

第9章 アジア太平洋のジェネリック医薬品市場:将来展望

  • 市場規模とその予測
  • 市場シェアとその予測
  • アジア太平洋市場:国別分析
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • 日本

第10章 中東・アフリカのジェネリック医薬品市場:将来展望

  • 市場規模とその予測
  • 市場シェアとその予測
  • 中東・アフリカ市場:国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦 (UAE)

第11章 南米のジェネリック医薬品市場:将来展望

  • 市場規模とその予測
  • 市場シェアとその予測
  • 南米市場:国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第12章 市場力学

  • 促進要因
  • 課題

第13章 市場の傾向と動静

第14章 競合情勢

  • 市場競争の見通し
  • 企業プロファイル
    • Teva Pharmaceutical Industries Ltd.
    • Mylan NV
    • Sandoz International GmbH (Novartis AG)
    • Lupin Limited
    • Pfizer Inc.
    • Sun Pharmaceutical Industries Limited
    • Endo Pharmaceuticals Inc.
    • Aurobindo Pharma Limited
    • Dr Reddy's Laboratories Ltd.
    • Fresenius Kabi AG
    • Aspen Pharmacare Holdings Limited
    • Sanofi SA
    • Cipla Ltd.
    • Novo Nordisk A/S
    • Abbott Laboratories Inc.

第15章 戦略提言

第16章 TechSci Researchについて、免責事項

図表

List of Figures

  • Figure 1: Global Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 2: Global Generic Drugs Market Share, By Type, 2016-2026F
  • Figure 3: Global Generic Drugs Market Share, By Application, 2016-2026F
  • Figure 4: Global Generic Drugs Market Share, By Drug Delivery, 2016-2026F
  • Figure 5: Global Generic Drugs Market Share, By Form, 2016-2026F
  • Figure 6: Global Generic Drugs Market Share, By Source, 2016-2026F
  • Figure 7: Global Generic Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 8: Global Generic Drugs Market Share, By Company, 2016-2026F
  • Figure 9: Global Generic Drugs Market Share, By Region, 2016-2026F
  • Figure 10: Global Generic Drugs Product Market Map, By Region, By Value, 2016-2026F
  • Figure 11: North America Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 12: North America Generic Drugs Market Share, By Type, 2016-2026F
  • Figure 13: North America Generic Drugs Market Share, By Application, 2016-2026F
  • Figure 14: North America Generic Drugs Market Share, By Drug Delivery, 2016-2026F
  • Figure 15: North America Generic Drugs Market Share, By Form, 2016-2026F
  • Figure 16: North America Generic Drugs Market Share, By Source, 2016-2026F
  • Figure 17: North America Generic Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 18: North America Generic Drugs Market Share, By Country, 2016-2026F
  • Figure 19: United States Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 20: United States Generic Drugs Market Share, By Type, 2016-2026F
  • Figure 21: United States Generic Drugs Market Share, By Application, 2016-2026F
  • Figure 22: United States Generic Drugs Market Share, By Drug Delivery, 2016-2026F
  • Figure 23: United States Generic Drugs Market Share, By Form, 2016-2026F
  • Figure 24: United States Generic Drugs Market Share, By Source, 2016-2026F
  • Figure 25: United States Generic Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 26: Canada Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 27: Canada Generic Drugs Market Share, By Type, 2016-2026F
  • Figure 28: Canada Generic Drugs Market Share, By Application, 2016-2026F
  • Figure 29: Canada Generic Drugs Market Share, By Drug Delivery, 2016-2026F
  • Figure 30: Canada Generic Drugs Market Share, By Form, 2016-2026F
  • Figure 31: Canada Generic Drugs Market Share, By Source, 2016-2026F
  • Figure 32: Canada Generic Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 33: Mexico Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 34: Mexico Generic Drugs Market Share, By Type, 2016-2026F
  • Figure 35: Mexico Generic Drugs Market Share, By Application, 2016-2026F
  • Figure 36: Mexico Generic Drugs Market Share, By Drug Delivery, 2016-2026F
  • Figure 37: Mexico Generic Drugs Market Share, By Form, 2016-2026F
  • Figure 38: Mexico Generic Drugs Market Share, By Source, 2016-2026F
  • Figure 39: Mexico Generic Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 40: Europe Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 41: Europe Generic Drugs Market Share, By Type, 2016-2026F
  • Figure 42: Europe Generic Drugs Market Share, By Application, 2016-2026F
  • Figure 43: Europe Generic Drugs Market Share, By Drug Delivery, 2016-2026F
  • Figure 44: Europe Generic Drugs Market Share, By Form, 2016-2026F
  • Figure 45: Europe Generic Drugs Market Share, By Source, 2016-2026F
  • Figure 46: Europe Generic Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 47: Europe Generic Drugs Market Share, By Country, 2016-2026F
  • Figure 48: Germany Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 49: Germany Generic Drugs Market Share, By Type, 2016-2026F
  • Figure 50: Germany Generic Drugs Market Share, By Application, 2016-2026F
  • Figure 51: Germany Generic Drugs Market Share, By Drug Delivery, 2016-2026F
  • Figure 52: Germany Generic Drugs Market Share, By Form, 2016-2026F
  • Figure 53: Germany Generic Drugs Market Share, By Source, 2016-2026F
  • Figure 54: Germany Generic Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 55: France Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 56: France Generic Drugs Market Share, By Type, 2016-2026F
  • Figure 57: France Generic Drugs Market Share, By Application, 2016-2026F
  • Figure 58: France Generic Drugs Market Share, By Drug Delivery, 2016-2026F
  • Figure 59: France Generic Drugs Market Share, By Form, 2016-2026F
  • Figure 60: France Generic Drugs Market Share, By Source, 2016-2026F
  • Figure 61: France Generic Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 62: United Kingdom Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 63: United Kingdom Generic Drugs Market Share, By Type, 2016-2026F
  • Figure 64: United Kingdom Generic Drugs Market Share, By Application, 2016-2026F
  • Figure 65: United Kingdom Generic Drugs Market Share, By Drug Delivery, 2016-2026F
  • Figure 66: United Kingdom Generic Drugs Market Share, By Form, 2016-2026F
  • Figure 67: United Kingdom Generic Drugs Market Share, By Source, 2016-2026F
  • Figure 68: United Kingdom Generic Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 69: Italy Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 70: Italy Generic Drugs Market Share, By Type, 2016-2026F
  • Figure 71: Italy Generic Drugs Market Share, By Application, 2016-2026F
  • Figure 72: Italy Generic Drugs Market Share, By Drug Delivery, 2016-2026F
  • Figure 73: Italy Generic Drugs Market Share, By Form, 2016-2026F
  • Figure 74: Italy Generic Drugs Market Share, By Source, 2016-2026F
  • Figure 75: Italy Generic Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 76: Spain Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 77: Spain Generic Drugs Market Share, By Type, 2016-2026F
  • Figure 78: Spain Generic Drugs Market Share, By Application, 2016-2026F
  • Figure 79: Spain Generic Drugs Market Share, By Drug Delivery, 2016-2026F
  • Figure 80: Spain Generic Drugs Market Share, By Form, 2016-2026F
  • Figure 81: Spain Generic Drugs Market Share, By Source, 2016-2026F
  • Figure 82: Spain Generic Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 83: Asia Pacific Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 84: Asia Pacific Generic Drugs Market Share, By Type, 2016-2026F
  • Figure 85: Asia Pacific Generic Drugs Market Share, By Application, 2016-2026F
  • Figure 86: Asia Pacific Generic Drugs Market Share, By Drug Delivery, 2016-2026F
  • Figure 87: Asia Pacific Generic Drugs Market Share, By Form, 2016-2026F
  • Figure 88: Asia Pacific Generic Drugs Market Share, By Source, 2016-2026F
  • Figure 89: Asia Pacific Generic Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 90: Asia Pacific Generic Drugs Market Share, By Country, 2016-2026F
  • Figure 91: China Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 92: China Generic Drugs Market Share, By Type, 2016-2026F
  • Figure 93: China Generic Drugs Market Share, By Application, 2016-2026F
  • Figure 94: China Generic Drugs Market Share, By Drug Delivery, 2016-2026F
  • Figure 95: China Generic Drugs Market Share, By Form, 2016-2026F
  • Figure 96: China Generic Drugs Market Share, By Source, 2016-2026F
  • Figure 97: China Generic Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 98: India Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 99: India Generic Drugs Market Share, By Type, 2016-2026F
  • Figure 100: India Generic Drugs Market Share, By Application, 2016-2026F
  • Figure 101: India Generic Drugs Market Share, By Drug Delivery, 2016-2026F
  • Figure 102: India Generic Drugs Market Share, By Form, 2016-2026F
  • Figure 103: India Generic Drugs Market Share, By Source, 2016-2026F
  • Figure 104: India Generic Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 105: Australia Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 106: Australia Generic Drugs Market Share, By Type, 2016-2026F
  • Figure 107: Australia Generic Drugs Market Share, By Application, 2016-2026F
  • Figure 108: Australia Generic Drugs Market Share, By Drug Delivery, 2016-2026F
  • Figure 109: Australia Generic Drugs Market Share, By Form, 2016-2026F
  • Figure 110: Australia Generic Drugs Market Share, By Source, 2016-2026F
  • Figure 111: Australia Generic Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 112: South Korea Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 113: South Korea Generic Drugs Market Share, By Type, 2016-2026F
  • Figure 114: South Korea Generic Drugs Market Share, By Application, 2016-2026F
  • Figure 115: South Korea Generic Drugs Market Share, By Drug Delivery, 2016-2026F
  • Figure 116: South Korea Generic Drugs Market Share, By Form, 2016-2026F
  • Figure 117: South Korea Generic Drugs Market Share, By Source, 2016-2026F
  • Figure 118: South Korea Generic Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 119: Japan Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 120: Japan Generic Drugs Market Share, By Type, 2016-2026F
  • Figure 121: Japan Generic Drugs Market Share, By Application, 2016-2026F
  • Figure 122: Japan Generic Drugs Market Share, By Drug Delivery, 2016-2026F
  • Figure 123: Japan Generic Drugs Market Share, By Form, 2016-2026F
  • Figure 124: Japan Generic Drugs Market Share, By Source, 2016-2026F
  • Figure 125: Japan Generic Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 126: South America Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 127: South America Generic Drugs Market Share, By Type, 2016-2026F
  • Figure 128: South America Generic Drugs Market Share, By Application, 2016-2026F
  • Figure 129: South America Generic Drugs Market Share, By Drug Delivery, 2016-2026F
  • Figure 130: South America Generic Drugs Market Share, By Form, 2016-2026F
  • Figure 131: South America Generic Drugs Market Share, By Source, 2016-2026F
  • Figure 132: South America Generic Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 133: South America Generic Drugs Market Share, By Country, 2016-2026F
  • Figure 134: Brazil Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 135: Brazil Generic Drugs Market Share, By Type, 2016-2026F
  • Figure 136: Brazil Generic Drugs Market Share, By Application, 2016-2026F
  • Figure 137: Brazil Generic Drugs Market Share, By Drug Delivery, 2016-2026F
  • Figure 138: Brazil Generic Drugs Market Share, By Form, 2016-2026F
  • Figure 139: Brazil Generic Drugs Market Share, By Source, 2016-2026F
  • Figure 140: Brazil Generic Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 141: Argentina Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 142: Argentina Generic Drugs Market Share, By Type, 2016-2026F
  • Figure 143: Argentina Generic Drugs Market Share, By Application, 2016-2026F
  • Figure 144: Argentina Generic Drugs Market Share, By Drug Delivery, 2016-2026F
  • Figure 145: Argentina Generic Drugs Market Share, By Form, 2016-2026F
  • Figure 146: Argentina Generic Drugs Market Share, By Source, 2016-2026F
  • Figure 147: Argentina Generic Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 148: Colombia Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 149: Colombia Generic Drugs Market Share, By Type, 2016-2026F
  • Figure 150: Colombia Generic Drugs Market Share, By Application, 2016-2026F
  • Figure 151: Colombia Generic Drugs Market Share, By Drug Delivery, 2016-2026F
  • Figure 152: Colombia Generic Drugs Market Share, By Form, 2016-2026F
  • Figure 153: Colombia Generic Drugs Market Share, By Source, 2016-2026F
  • Figure 154: Colombia Generic Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 155: Middle East & Africa Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 156: Middle East & Africa Generic Drugs Market Share, By Type, 2016-2026F
  • Figure 157: Middle East & Africa Generic Drugs Market Share, By Application, 2016-2026F
  • Figure 158: Middle East & Africa Generic Drugs Market Share, By Drug Delivery, 2016-2026F
  • Figure 159: Middle East & Africa Generic Drugs Market Share, By Form, 2016-2026F
  • Figure 160: Middle East & Africa Generic Drugs Market Share, By Source, 2016-2026F
  • Figure 161: Middle East & Africa Generic Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 162: Middle East & Africa Generic Drugs Market Share, By Country, 2016-2026F
  • Figure 163: South Africa Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 164: South Africa Generic Drugs Market Share, By Type, 2016-2026F
  • Figure 165: South Africa Generic Drugs Market Share, By Application, 2016-2026F
  • Figure 166: South Africa Generic Drugs Market Share, By Drug Delivery, 2016-2026F
  • Figure 167: South Africa Generic Drugs Market Share, By Form, 2016-2026F
  • Figure 168: South Africa Generic Drugs Market Share, By Source, 2016-2026F
  • Figure 169: South Africa Generic Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 170: Saudi Arabia Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 171: Saudi Arabia Generic Drugs Market Share, By Type, 2016-2026F
  • Figure 172: Saudi Arabia Generic Drugs Market Share, By Application, 2016-2026F
  • Figure 173: Saudi Arabia Generic Drugs Market Share, By Drug Delivery, 2016-2026F
  • Figure 174: Saudi Arabia Generic Drugs Market Share, By Form, 2016-2026F
  • Figure 175: Saudi Arabia Generic Drugs Market Share, By Source, 2016-2026F
  • Figure 176: Saudi Arabia Generic Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 180: UAE Generic Drugs Market Size, By Value (USD Billion), 2016-2026F
  • Figure 181: UAE Generic Drugs Market Share, By Type, 2016-2026F
  • Figure 182: UAE Generic Drugs Market Share, By Application, 2016-2026F
  • Figure 183: UAE Generic Drugs Market Share, By Drug Delivery, 2016-2026F
  • Figure 184: UAE Generic Drugs Market Share, By Form, 2016-2026F
  • Figure 185: UAE Generic Drugs Market Share, By Source, 2016-2026F
  • Figure 186: UAE Generic Drugs Market Share, By Distribution Channel, 2016-2026F
目次
Product Code: 7332

Title:
Global Generic Drugs Market, By Type (Small Molecule Generics vs Biosimilars), By Application (Cardiovascular Diseases, Diabetes, Neurology, Oncology, Anti-Inflammatory Diseases, Others), By Drug Delivery (Oral, Topical, Parenteral, Others), By Form (Tablet, Capsule, Injection, Others), By Source (In House vs Contract Manufacturing Organizations), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By Company, By Region, Forecast & Opportunities, 2026.

Global generic drugs market was valued at USD371.04 billion in 2020 and is anticipated to reach USD564.43 billion until 2026 by witnessing a CAGR of 7.08% during the forecast period. The global generic drugs market is driven by rising prevalence of chronic diseases across the globe. Moreover, availability of generic drugs at a lower cost and having the same chemical composition of branded drugs is one of the key factors which is positively impacting the growth of market during the forecast period. Also, increasing count of drug patent expirations is further expected to bolster the growth of market over the next few years.

The global generic drugs market is segmented based on type, application, drug delivery, form, source, distribution channel, company, and region. In terms of application, the market can be categorized into cardiovascular diseases, diabetes, neurology, oncology, anti-inflammatory diseases, others. Out of which, the cardiovascular diseases segment dominated the market by holding 35.05% market share in 2020 and the segment is expected to maintain its leading position in the market during the forecast period as well. This can be ascribed to majority of population dealing with cardiovascular diseases across the globe. On the contrary, diabetes segment is anticipated to register the highest growth in the coming years which can be attributed to ever increasing prevalence of diabetes predominantly in Asia-Pacific region. Also, growing use of metformin generic drug for the treatment of diabetes owing to its effectiveness, is further contributing to the segmental growth.

The major players operating in the global generic drugs market are Teva Pharmaceutical Industries Ltd, Mylan NV, Sandoz International GmbH (Novartis AG), Lupin Limited, Pfizer Inc., Sun Pharmaceutical Industries Limited, Endo Pharmaceuticals Inc., Aurobindo Pharma Limited, Dr Reddy's Laboratories Ltd., Fresenius Kabi AG, Aspen Pharmacare Holdings Limited, Sanofi S.A., Cipla Ltd., Novo Nordisk A/S, Abbott Laboratories Inc., and others. Major companies are developing advanced technologies and launching new products to stay competitive in the market. Other competitive strategies include mergers & acquisitions, partnership, agreements, and new developments in order to expand their geographic reach and to increase their customer base.

Years considered for this report:

Historical Years: 2016-2019

Base Year: 2020

Estimated Year: 2021

Forecast Period: 2022-2026

Objective of the Study:

  • To analyze historical growth in market size of global generic drugs market from 2016 to 2019.
  • To estimate and forecast the market size of global generic drugs market from 2021 to 2026 and growth rate until 2026.
  • To classify and forecast global generic drugs market based on type, application, drug delivery, form, source, distribution channel, company and regional distribution.
  • To identify dominant region or segment in the global generic drugs market.
  • To identify drivers and challenges for global generic drugs market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global generic drugs market.
  • To conduct pricing analysis for global generic drugs market.
  • To identify and analyze the profiles of leading players operating in global generic drugs market.
  • To identify key sustainable strategies adopted by market players in global generic drugs market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the products and presence of all major players across the globe.

TechSci Research calculated the market size of global generic drugs market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these services and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Generic drugs manufacturers
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to generic drugs

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global generic drugs market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Generic Drugs Market, By Type:

Small Molecule Generics

Biosimilars

  • Global Generic Drugs Market, By Application:

Cardiovascular Diseases

Diabetes

Neurology

Oncology

Anti-Inflammatory Diseases

Others

  • Global Generic Drugs Market, By Drug Delivery:

Oral

Topical

Parenteral

Others

  • Global Generic Drugs Market, By Form:

Tablet

Capsule

Injection

Others

  • Global Generic Drugs Market, By Source:

In House

Contract Manufacturing Organizations

  • Global Generic Drugs Market, By Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Others

  • Global Generic Drugs Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape:

Company Profiles: Detailed analysis of the major companies present in global generic drugs market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information:

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Generic Drugs Market

4. Executive Summary

5. Voice of Customer

  • 5.1. Brand Awareness
  • 5.2. Factors driving Global Generic Drugs Market
  • 5.3. Factors Influencing Drug Purchase Decision

6. Global Generic Drugs Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type (Small Molecule Generics vs Biosimilars)
    • 6.2.2. By Application (Cardiovascular Diseases, Diabetes, Neurology, Oncology, Anti-Inflammatory Diseases, Others)
    • 6.2.3. By Drug Delivery (Oral, Topical, Parenteral, Others)
    • 6.2.4. By Form (Tablet, Capsule, Injection, Others)
    • 6.2.5. By Source (In House vs Contract Manufacturing Organizations)
    • 6.2.6. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others
    • 6.2.7. By Region
    • 6.2.8. By Company (2020)
  • 6.3. Product Market Map

7. North America Generic Drugs Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Application
    • 7.2.3. By Drug Delivery
    • 7.2.4. By Form
    • 7.2.5. By Source
    • 7.2.6. By Distribution Channel
    • 7.2.7. By Country (United States; Canada; Mexico)
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Generic Drugs Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By Drug Delivery
        • 7.3.1.2.4. By Form
        • 7.3.1.2.5. By Source
        • 7.3.1.2.6. By Distribution Channel
    • 7.3.2. Canada Generic Drugs Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By Drug Delivery
        • 7.3.2.2.4. By Form
        • 7.3.2.2.5. By Source
        • 7.3.2.2.6. By Distribution Channel
    • 7.3.3. Mexico Generic Drugs Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By Drug Delivery
        • 7.3.3.2.4. By Form
        • 7.3.3.2.5. By Source
        • 7.3.3.2.6. By Distribution Channel

8. Europe Generic Drugs Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By Drug Delivery
    • 8.2.4. By Form
    • 8.2.5. By Source
    • 8.2.6. By Distribution Channel
    • 8.2.7. By Country (France; Germany; UK; Italy; Spain)
  • 8.3. Europe: Country Analysis
    • 8.3.1. Germany Generic Drugs Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By Drug Delivery
        • 8.3.1.2.4. By Form
        • 8.3.1.2.5. By Source
        • 8.3.1.2.6. By Distribution Channel
    • 8.3.2. France Generic Drugs Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By Drug Delivery
        • 8.3.2.2.4. By Form
        • 8.3.2.2.5. By Source
        • 8.3.2.2.6. By Distribution Channel
    • 8.3.3. United Kingdom Generic Drugs Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By Drug Delivery
        • 8.3.3.2.4. By Form
        • 8.3.3.2.5. By Source
        • 8.3.3.2.6. By Distribution Channel
    • 8.3.4. Italy Generic Drugs Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By Drug Delivery
        • 8.3.4.2.4. By Form
        • 8.3.4.2.5. By Source
        • 8.3.4.2.6. By Distribution Channel
    • 8.3.5. Spain Generic Drugs Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By Drug Delivery
        • 8.3.5.2.4. By Form
        • 8.3.5.2.5. By Source
        • 8.3.5.2.6. By Distribution Channel

9. Asia-Pacific Generic Drugs Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Application
    • 9.2.3. By Drug Delivery
    • 9.2.4. By Form
    • 9.2.5. By Source
    • 9.2.6. By Distribution Channel
    • 9.2.7. By Country (China; India; Japan; South Korea; Australia)
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Generic Drugs Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By Drug Delivery
        • 9.3.1.2.4. By Form
        • 9.3.1.2.5. By Source
        • 9.3.1.2.6. By Distribution Channel
    • 9.3.2. India Generic Drugs Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By Drug Delivery
        • 9.3.2.2.4. By Form
        • 9.3.2.2.5. By Source
        • 9.3.2.2.6. By Distribution Channel
    • 9.3.3. Australia Generic Drugs Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By Drug Delivery
        • 9.3.3.2.4. By Form
        • 9.3.3.2.5. By Source
        • 9.3.3.2.6. By Distribution Channel
    • 9.3.4. South Korea Generic Drugs Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Type
        • 9.3.4.2.2. By Application
        • 9.3.4.2.3. By Drug Delivery
        • 9.3.4.2.4. By Form
        • 9.3.4.2.5. By Source
        • 9.3.4.2.6. By Distribution Channel
    • 9.3.5. Japan Generic Drugs Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Type
        • 9.3.5.2.2. By Application
        • 9.3.5.2.3. By Drug Delivery
        • 9.3.5.2.4. By Form
        • 9.3.5.2.5. By Source
        • 9.3.5.2.6. By Distribution Channel

10. Middle East and Africa Generic Drugs Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Application
    • 10.2.3. By Drug Delivery
    • 10.2.4. By Form
    • 10.2.5. By Source
    • 10.2.6. By Distribution Channel
    • 10.2.7. By Country (UAE; Saudi Arabia; South Africa)
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Generic Drugs Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By Drug Delivery
        • 10.3.1.2.4. By Form
        • 10.3.1.2.5. By Source
        • 10.3.1.2.6. By Distribution Channel
    • 10.3.2. Saudi Arabia Generic Drugs Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By Drug Delivery
        • 10.3.2.2.4. By Form
        • 10.3.2.2.5. By Source
        • 10.3.2.2.6. By Distribution Channel
    • 10.3.3. UAE Generic Drugs Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By Drug Delivery
        • 10.3.3.2.4. By Form
        • 10.3.3.2.5. By Source
        • 10.3.3.2.6. By Distribution Channel

11. South America Generic Drugs Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Type
    • 11.2.2. By Application
    • 11.2.3. By Drug Delivery
    • 11.2.4. By Form
    • 11.2.5. By Source
    • 11.2.6. By Distribution Channel
    • 11.2.7. By Country (Brazil; Argentina; Colombia)
  • 11.3. South America: Country Analysis
    • 11.3.1. Brazil Generic Drugs Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Type
        • 11.3.1.2.2. By Application
        • 11.3.1.2.3. By Drug Delivery
        • 11.3.1.2.4. By Form
        • 11.3.1.2.5. By Source
        • 11.3.1.2.6. By Distribution Channel
    • 11.3.2. Argentina Generic Drugs Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Type
        • 11.3.2.2.2. By Application
        • 11.3.2.2.3. By Drug Delivery
        • 11.3.2.2.4. By Form
        • 11.3.2.2.5. By Source
        • 11.3.2.2.6. By Distribution Channel
    • 11.3.3. Colombia Generic Drugs Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Type
        • 11.3.3.2.2. By Application
        • 11.3.3.2.3. By Drug Delivery
        • 11.3.3.2.4. By Form
        • 11.3.3.2.5. By Source
        • 11.3.3.2.6. By Distribution Channel

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Competition Outlook
  • 14.2. Company Profiles
    • 14.2.1. Teva Pharmaceutical Industries Ltd.
    • 14.2.2. Mylan NV
    • 14.2.3. Sandoz International GmbH (Novartis AG)
    • 14.2.4. Lupin Limited
    • 14.2.5. Pfizer Inc.
    • 14.2.6. Sun Pharmaceutical Industries Limited
    • 14.2.7. Endo Pharmaceuticals Inc.
    • 14.2.8. Aurobindo Pharma Limited
    • 14.2.9. Dr Reddy's Laboratories Ltd.
    • 14.2.10. Fresenius Kabi AG
    • 14.2.11. Aspen Pharmacare Holdings Limited
    • 14.2.12. Sanofi SA
    • 14.2.13. Cipla Ltd.
    • 14.2.14. Novo Nordisk A/S
    • 14.2.15. Abbott Laboratories Inc.

15. Strategic Recommendations

16. About Us and Disclaimer

株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.